reference/2927899

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2927899

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	96
issn	1365-2141 0007-1048
issueIdentifier	1
pageRange	89-96
publicationName	British Journal of Haematology
startingPage	89
bibliographicCitation	Juliusson G, Celsing F, Turesson I, Lenhoff S, Adriansson M, Malm C. Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma. Br J Haematol. 2000 Apr;109(1):89–96. doi: 10.1046/j.1365-2141.2000.01983.x. PMID: 10848786.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b95ca0994607f78a222c5c9488d58972 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb8b335f934a3ac59ba1f21af91ed717 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b64ff53471c71968139cba343926b46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_562d8eef7d7c7e02a743aaef9b8ea65e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81718ff763a072510d669f7a32eea724 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf250bac916454a66dee9be7a03cb8c5
date	200004
identifier	https://pubmed.ncbi.nlm.nih.gov/10848786 https://doi.org/10.1046/j.1365-2141.2000.01983.x
isPartOf	https://portal.issn.org/resource/ISSN/0007-1048 https://portal.issn.org/resource/ISSN/1365-2141 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1822
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma
discusses	http://id.nlm.nih.gov/mesh/M0011000 http://id.nlm.nih.gov/mesh/M0010885 http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0002304
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D020533Q000008 http://id.nlm.nih.gov/mesh/D013792Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D013792Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D014717Q000139 http://id.nlm.nih.gov/mesh/D007070Q000097 http://id.nlm.nih.gov/mesh/D019964Q000139 http://id.nlm.nih.gov/mesh/D009101Q000652 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006993Q000009 http://id.nlm.nih.gov/mesh/D006993Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D009101Q000276 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D001536Q000652 http://id.nlm.nih.gov/mesh/D020533Q000009 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6957 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8140 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8911 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8658 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790759

Total number of triples: 71.